APO Research
Talk to an analyst

APO RESEARCH · REPORT

Digital Therapeutics (DTx) For Mental Health

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Digital Therapeutics (DTx) For Mental Health Market Analysis and Forecast 2026-2032

12 August 2026177 pages

Choose your research edition.

Industry ResearchDigital Therapeutics (DTx) For Mental Health Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Therapeutics (DTx) For Mental Health Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Digital Therapeutics (DTx) For Mental Health Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Therapeutics (DTx) For Mental Health Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Digital Therapeutics (DTx) For Mental Health Market Analysis and Forecast 2026-2032177 pages · $4,950 USD

Market perspective

The global Digital Therapeutics (DTx) For Mental Health market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Digital Therapeutics (DTx) For Mental Health is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Digital Therapeutics (DTx) For Mental Health is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Digital Therapeutics (DTx) For Mental Health is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Digital Therapeutics (DTx) For Mental Health is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Digital Therapeutics (DTx) For Mental Health include WellDoc, Pear Therapeutics, COGNIFIT, Ginger, Propeller Health, 2morrow, Canary Health, Noom and Teladoc Health, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Digital Therapeutics (DTx) For Mental Health, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Digital Therapeutics (DTx) For Mental Health, also provides the revenue of main regions and countries. Of the upcoming market potential for Digital Therapeutics (DTx) For Mental Health, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Digital Therapeutics (DTx) For Mental Health revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Digital Therapeutics (DTx) For Mental Health market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Digital Therapeutics (DTx) For Mental Health revenue, projected growth trends, production technology, application and end-user industry.

Digital Therapeutics (DTx) For Mental Health Segment by Company

WellDoc

Pear Therapeutics

COGNIFIT

Ginger

Propeller Health

2morrow

Canary Health

Noom

Teladoc Health

Omada Health

Digital Therapeutics (DTx) For Mental Health Segment by Type

Biology Modifying Drugs

Gene Therapies

Cell Therapies

Digital Therapeutics (DTx) For Mental Health Segment by Application

Pharmaceutical Companies

Academic and Research Institutions

Others

Digital Therapeutics (DTx) For Mental Health Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Therapeutics (DTx) For Mental Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Therapeutics (DTx) For Mental Health and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Therapeutics (DTx) For Mental Health.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Digital Therapeutics (DTx) For Mental Health in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Digital Therapeutics (DTx) For Mental Health company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digital Therapeutics (DTx) For Mental Health revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Digital Therapeutics (DTx) For Mental Health Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Biology Modifying Drugs Major Player Table 3. Gene Therapies Major Player Table 4. Cell Therapies Major Player Table 5. Global Digital Therapeutics (DTx) For Mental Health Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Pharmaceutical Companies Major Player Table 7. Academic and Research Institutions Major Player Table 8. Others Major Player Table 9. Digital Therapeutics (DTx) For Mental Health Industry Trends Table 10. Digital Therapeutics (DTx) For Mental Health Industry Drivers Table 11. Digital Therapeutics (DTx) For Mental Health Industry Opportunities and Challenges Table 12. Digital Therapeutics (DTx) For Mental Health Industry Restraints Table 13. Global Digital Therapeutics (DTx) For Mental Health Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Digital Therapeutics (DTx) For Mental Health Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Digital Therapeutics (DTx) For Mental Health Market Share by Region (2021-2026) Table 16. Global Digital Therapeutics (DTx) For Mental Health Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Digital Therapeutics (DTx) For Mental Health Market Share by Region (2027-2032) Table 18. Global Digital Therapeutics (DTx) For Mental Health Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Digital Therapeutics (DTx) For Mental Health Revenue Market Share by Players (2021-2026) Table 20. Global Digital Therapeutics (DTx) For Mental Health Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Digital Therapeutics (DTx) For Mental Health Key Players Headquarters & Area Served Table 22. Global Digital Therapeutics (DTx) For Mental Health Players, Product Type & Application Table 23. Global Digital Therapeutics (DTx) For Mental Health Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Digital Therapeutics (DTx) For Mental Health by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Digital Therapeutics (DTx) For Mental Health Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Digital Therapeutics (DTx) For Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Digital Therapeutics (DTx) For Mental Health Revenue Market Share by Type (2021-2026) Table 30. Global Digital Therapeutics (DTx) For Mental Health Revenue Market Share by Type (2027-2032) Table 31. Global Digital Therapeutics (DTx) For Mental Health Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Digital Therapeutics (DTx) For Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Digital Therapeutics (DTx) For Mental Health Revenue Market Share by Application (2021-2026) Table 35. Global Digital Therapeutics (DTx) For Mental Health Revenue Market Share by Application (2027-2032) Table 36. WellDoc Company Information Table 37. WellDoc Business Overview Table 38. WellDoc Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. WellDoc Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 40. WellDoc Recent Development Table 41. Pear Therapeutics Company Information Table 42. Pear Therapeutics Business Overview Table 43. Pear Therapeutics Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Pear Therapeutics Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 45. Pear Therapeutics Recent Development Table 46. COGNIFIT Company Information Table 47. COGNIFIT Business Overview Table 48. COGNIFIT Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. COGNIFIT Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 50. COGNIFIT Recent Development Table 51. Ginger Company Information Table 52. Ginger Business Overview Table 53. Ginger Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Ginger Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 55. Ginger Recent Development Table 56. Propeller Health Company Information Table 57. Propeller Health Business Overview Table 58. Propeller Health Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Propeller Health Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 60. Propeller Health Recent Development Table 61. 2morrow Company Information Table 62. 2morrow Business Overview Table 63. 2morrow Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. 2morrow Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 65. 2morrow Recent Development Table 66. Canary Health Company Information Table 67. Canary Health Business Overview Table 68. Canary Health Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Canary Health Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 70. Canary Health Recent Development Table 71. Noom Company Information Table 72. Noom Business Overview Table 73. Noom Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Noom Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 75. Noom Recent Development Table 76. Teladoc Health Company Information Table 77. Teladoc Health Business Overview Table 78. Teladoc Health Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Teladoc Health Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 80. Teladoc Health Recent Development Table 81. Omada Health Company Information Table 82. Omada Health Business Overview Table 83. Omada Health Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Omada Health Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 85. Omada Health Recent Development Table 86. North America Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Digital Therapeutics (DTx) For Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Digital Therapeutics (DTx) For Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Digital Therapeutics (DTx) For Mental Health Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Digital Therapeutics (DTx) For Mental Health Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Digital Therapeutics (DTx) For Mental Health Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Digital Therapeutics (DTx) For Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Digital Therapeutics (DTx) For Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Digital Therapeutics (DTx) For Mental Health Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Digital Therapeutics (DTx) For Mental Health Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Digital Therapeutics (DTx) For Mental Health Revenue by Country (US$ Million) & (2027-2032) Table 100. China Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 101. China Digital Therapeutics (DTx) For Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 102. China Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 103. China Digital Therapeutics (DTx) For Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Digital Therapeutics (DTx) For Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Digital Therapeutics (DTx) For Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Digital Therapeutics (DTx) For Mental Health Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Digital Therapeutics (DTx) For Mental Health Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Digital Therapeutics (DTx) For Mental Health Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Digital Therapeutics (DTx) For Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Digital Therapeutics (DTx) For Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Digital Therapeutics (DTx) For Mental Health Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Digital Therapeutics (DTx) For Mental Health Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Digital Therapeutics (DTx) For Mental Health Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Digital Therapeutics (DTx) For Mental Health Image Figure 2. Global Digital Therapeutics (DTx) For Mental Health Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Therapeutics (DTx) For Mental Health Market Size Share 2021 VS 2025 VS 2032 Figure 4. Biology Modifying Drugs Image Figure 5. Gene Therapies Image Figure 6. Cell Therapies Image Figure 7. Global Digital Therapeutics (DTx) For Mental Health Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Digital Therapeutics (DTx) For Mental Health Market Size Share 2021 VS 2025 VS 2032 Figure 9. Pharmaceutical Companies Image Figure 10. Academic and Research Institutions Image Figure 11. Others Image Figure 12. Global Digital Therapeutics (DTx) For Mental Health Market Size (US$ Million) & (2021-2032) Figure 13. Global Digital Therapeutics (DTx) For Mental Health Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Digital Therapeutics (DTx) For Mental Health Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Digital Therapeutics (DTx) For Mental Health Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Digital Therapeutics (DTx) For Mental Health Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Digital Therapeutics (DTx) For Mental Health Revenue Market Share by Type (2021-2032) Figure 20. Global Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Digital Therapeutics (DTx) For Mental Health Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Digital Therapeutics (DTx) For Mental Health Revenue Market Share by Application (2021-2032) Figure 23. North America Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Digital Therapeutics (DTx) For Mental Health Revenue Share by Type (2021-2032) Figure 25. North America Digital Therapeutics (DTx) For Mental Health Revenue Share by Application (2021-2032) Figure 26. North America Digital Therapeutics (DTx) For Mental Health Revenue Share by Country (2021-2032) Figure 27. United States Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Digital Therapeutics (DTx) For Mental Health Revenue Share by Type (2021-2032) Figure 32. Europe Digital Therapeutics (DTx) For Mental Health Revenue Share by Application (2021-2032) Figure 33. Europe Digital Therapeutics (DTx) For Mental Health Revenue Share by Country (2021-2032) Figure 34. Germany Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Digital Therapeutics (DTx) For Mental Health Revenue Share by Type (2021-2032) Figure 44. China Digital Therapeutics (DTx) For Mental Health Revenue Share by Application (2021-2032) Figure 45. Asia Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Digital Therapeutics (DTx) For Mental Health Revenue Share by Type (2021-2032) Figure 47. Asia Digital Therapeutics (DTx) For Mental Health Revenue Share by Application (2021-2032) Figure 48. Asia Digital Therapeutics (DTx) For Mental Health Revenue Share by Region (2021-2032) Figure 49. Japan Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Digital Therapeutics (DTx) For Mental Health Revenue Share by Type (2021-2032) Figure 57. SAMEA Digital Therapeutics (DTx) For Mental Health Revenue Share by Application (2021-2032) Figure 58. SAMEA Digital Therapeutics (DTx) For Mental Health Revenue Share by Country (2021-2032) Figure 59. Brazil Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Digital Therapeutics (DTx) For Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Biology Modifying Drugs
  • Gene Therapies
  • Cell Therapies
Applications
  • Pharmaceutical Companies
  • Academic and Research Institutions
  • Others
Companies covered
  • WellDoc
  • Pear Therapeutics
  • COGNIFIT
  • Ginger
  • Propeller Health
  • 2morrow
  • Canary Health
  • Noom
  • Teladoc Health
  • Omada Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Digital Therapeutics (DTx) For Mental Health Market by Type
  3. 1.2.1 Global Digital Therapeutics (DTx) For Mental Health Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Biology Modifying Drugs
  5. 1.2.3 Gene Therapies
  6. 1.2.4 Cell Therapies
  7. 1.3 Digital Therapeutics (DTx) For Mental Health Market by Application
  8. 1.3.1 Global Digital Therapeutics (DTx) For Mental Health Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmaceutical Companies
  10. 1.3.3 Academic and Research Institutions
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Digital Therapeutics (DTx) For Mental Health Market Dynamics
  1. 2.1 Digital Therapeutics (DTx) For Mental Health Industry Trends
  2. 2.2 Digital Therapeutics (DTx) For Mental Health Industry Drivers
  3. 2.3 Digital Therapeutics (DTx) For Mental Health Industry Opportunities and Challenges
  4. 2.4 Digital Therapeutics (DTx) For Mental Health Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Digital Therapeutics (DTx) For Mental Health Market Perspective (2021-2032)
  2. 3.2 Global Digital Therapeutics (DTx) For Mental Health Growth Trends by Region
  3. 3.2.1 Global Digital Therapeutics (DTx) For Mental Health Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Digital Therapeutics (DTx) For Mental Health Market Size by Region (2021-2026)
  5. 3.2.3 Global Digital Therapeutics (DTx) For Mental Health Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Digital Therapeutics (DTx) For Mental Health Revenue by Players
  2. 4.1.1 Global Digital Therapeutics (DTx) For Mental Health Revenue by Players (2021-2026)
  3. 4.1.2 Global Digital Therapeutics (DTx) For Mental Health Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Digital Therapeutics (DTx) For Mental Health Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Digital Therapeutics (DTx) For Mental Health Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Digital Therapeutics (DTx) For Mental Health Key Players Headquarters & Area Served
  7. 4.4 Global Digital Therapeutics (DTx) For Mental Health Players, Product Type & Application
  8. 4.5 Global Digital Therapeutics (DTx) For Mental Health Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Digital Therapeutics (DTx) For Mental Health Market CR5 and HHI
  11. 4.6.3 2025 Digital Therapeutics (DTx) For Mental Health Tier 1, Tier 2, and Tier 3
5 Digital Therapeutics (DTx) For Mental Health Market Size by Type
  1. 5.1 Global Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021-2032)
  3. 5.3 Global Digital Therapeutics (DTx) For Mental Health Revenue Market Share by Type (2021-2032)
6 Digital Therapeutics (DTx) For Mental Health Market Size by Application
  1. 6.1 Global Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021-2032)
  3. 6.3 Global Digital Therapeutics (DTx) For Mental Health Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 WellDoc
  2. 7.1.1 WellDoc Company Information
  3. 7.1.2 WellDoc Business Overview
  4. 7.1.3 WellDoc Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  5. 7.1.4 WellDoc Digital Therapeutics (DTx) For Mental Health Product Portfolio
  6. 7.1.5 WellDoc Recent Developments
  7. 7.2 Pear Therapeutics
  8. 7.2.1 Pear Therapeutics Company Information
  9. 7.2.2 Pear Therapeutics Business Overview
  10. 7.2.3 Pear Therapeutics Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Pear Therapeutics Digital Therapeutics (DTx) For Mental Health Product Portfolio
  12. 7.2.5 Pear Therapeutics Recent Developments
  13. 7.3 COGNIFIT
  14. 7.3.1 COGNIFIT Company Information
  15. 7.3.2 COGNIFIT Business Overview
  16. 7.3.3 COGNIFIT Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  17. 7.3.4 COGNIFIT Digital Therapeutics (DTx) For Mental Health Product Portfolio
  18. 7.3.5 COGNIFIT Recent Developments
  19. 7.4 Ginger
  20. 7.4.1 Ginger Company Information
  21. 7.4.2 Ginger Business Overview
  22. 7.4.3 Ginger Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Ginger Digital Therapeutics (DTx) For Mental Health Product Portfolio
  24. 7.4.5 Ginger Recent Developments
  25. 7.5 Propeller Health
  26. 7.5.1 Propeller Health Company Information
  27. 7.5.2 Propeller Health Business Overview
  28. 7.5.3 Propeller Health Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Propeller Health Digital Therapeutics (DTx) For Mental Health Product Portfolio
  30. 7.5.5 Propeller Health Recent Developments
  31. 7.6 2morrow
  32. 7.6.1 2morrow Company Information
  33. 7.6.2 2morrow Business Overview
  34. 7.6.3 2morrow Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  35. 7.6.4 2morrow Digital Therapeutics (DTx) For Mental Health Product Portfolio
  36. 7.6.5 2morrow Recent Developments
  37. 7.7 Canary Health
  38. 7.7.1 Canary Health Company Information
  39. 7.7.2 Canary Health Business Overview
  40. 7.7.3 Canary Health Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Canary Health Digital Therapeutics (DTx) For Mental Health Product Portfolio
  42. 7.7.5 Canary Health Recent Developments
  43. 7.8 Noom
  44. 7.8.1 Noom Company Information
  45. 7.8.2 Noom Business Overview
  46. 7.8.3 Noom Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Noom Digital Therapeutics (DTx) For Mental Health Product Portfolio
  48. 7.8.5 Noom Recent Developments
  49. 7.9 Teladoc Health
  50. 7.9.1 Teladoc Health Company Information
  51. 7.9.2 Teladoc Health Business Overview
  52. 7.9.3 Teladoc Health Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Teladoc Health Digital Therapeutics (DTx) For Mental Health Product Portfolio
  54. 7.9.5 Teladoc Health Recent Developments
  55. 7.10 Omada Health
  56. 7.10.1 Omada Health Company Information
  57. 7.10.2 Omada Health Business Overview
  58. 7.10.3 Omada Health Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Omada Health Digital Therapeutics (DTx) For Mental Health Product Portfolio
  60. 7.10.5 Omada Health Recent Developments
8 North America
  1. 8.1 North America Digital Therapeutics (DTx) For Mental Health Revenue (2021-2032)
  2. 8.2 North America Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021-2032)
  3. 8.2.1 North America Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021-2026)
  4. 8.2.2 North America Digital Therapeutics (DTx) For Mental Health Revenue by Type (2027-2032)
  5. 8.3 North America Digital Therapeutics (DTx) For Mental Health Revenue Share by Type (2021-2032)
  6. 8.4 North America Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021-2032)
  7. 8.4.1 North America Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021-2026)
  8. 8.4.2 North America Digital Therapeutics (DTx) For Mental Health Revenue by Application (2027-2032)
  9. 8.5 North America Digital Therapeutics (DTx) For Mental Health Revenue Share by Application (2021-2032)
  10. 8.6 North America Digital Therapeutics (DTx) For Mental Health Revenue by Country
  11. 8.6.1 North America Digital Therapeutics (DTx) For Mental Health Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Digital Therapeutics (DTx) For Mental Health Revenue by Country (2021-2026)
  13. 8.6.3 North America Digital Therapeutics (DTx) For Mental Health Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Digital Therapeutics (DTx) For Mental Health Revenue (2021-2032)
  2. 9.2 Europe Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021-2032)
  3. 9.2.1 Europe Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021-2026)
  4. 9.2.2 Europe Digital Therapeutics (DTx) For Mental Health Revenue by Type (2027-2032)
  5. 9.3 Europe Digital Therapeutics (DTx) For Mental Health Revenue Share by Type (2021-2032)
  6. 9.4 Europe Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021-2032)
  7. 9.4.1 Europe Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021-2026)
  8. 9.4.2 Europe Digital Therapeutics (DTx) For Mental Health Revenue by Application (2027-2032)
  9. 9.5 Europe Digital Therapeutics (DTx) For Mental Health Revenue Share by Application (2021-2032)
  10. 9.6 Europe Digital Therapeutics (DTx) For Mental Health Revenue by Country
  11. 9.6.1 Europe Digital Therapeutics (DTx) For Mental Health Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Digital Therapeutics (DTx) For Mental Health Revenue by Country (2021-2026)
  13. 9.6.3 Europe Digital Therapeutics (DTx) For Mental Health Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Digital Therapeutics (DTx) For Mental Health Revenue (2021-2032)
  2. 10.2 China Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021-2032)
  3. 10.2.1 China Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021-2026)
  4. 10.2.2 China Digital Therapeutics (DTx) For Mental Health Revenue by Type (2027-2032)
  5. 10.3 China Digital Therapeutics (DTx) For Mental Health Revenue Share by Type (2021-2032)
  6. 10.4 China Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021-2032)
  7. 10.4.1 China Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021-2026)
  8. 10.4.2 China Digital Therapeutics (DTx) For Mental Health Revenue by Application (2027-2032)
  9. 10.5 China Digital Therapeutics (DTx) For Mental Health Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Digital Therapeutics (DTx) For Mental Health Revenue (2021-2032)
  2. 11.2 Asia Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021-2032)
  3. 11.2.1 Asia Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021-2026)
  4. 11.2.2 Asia Digital Therapeutics (DTx) For Mental Health Revenue by Type (2027-2032)
  5. 11.3 Asia Digital Therapeutics (DTx) For Mental Health Revenue Share by Type (2021-2032)
  6. 11.4 Asia Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021-2032)
  7. 11.4.1 Asia Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021-2026)
  8. 11.4.2 Asia Digital Therapeutics (DTx) For Mental Health Revenue by Application (2027-2032)
  9. 11.5 Asia Digital Therapeutics (DTx) For Mental Health Revenue Share by Application (2021-2032)
  10. 11.6 Asia Digital Therapeutics (DTx) For Mental Health Revenue by Country
  11. 11.6.1 Asia Digital Therapeutics (DTx) For Mental Health Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Digital Therapeutics (DTx) For Mental Health Revenue by Country (2021-2026)
  13. 11.6.3 Asia Digital Therapeutics (DTx) For Mental Health Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Digital Therapeutics (DTx) For Mental Health Revenue (2021-2032)
  2. 12.2 SAMEA Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Digital Therapeutics (DTx) For Mental Health Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Digital Therapeutics (DTx) For Mental Health Revenue by Type (2027-2032)
  5. 12.3 SAMEA Digital Therapeutics (DTx) For Mental Health Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Digital Therapeutics (DTx) For Mental Health Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Digital Therapeutics (DTx) For Mental Health Revenue by Application (2027-2032)
  9. 12.5 SAMEA Digital Therapeutics (DTx) For Mental Health Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Digital Therapeutics (DTx) For Mental Health Revenue by Country
  11. 12.6.1 SAMEA Digital Therapeutics (DTx) For Mental Health Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Digital Therapeutics (DTx) For Mental Health Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Digital Therapeutics (DTx) For Mental Health Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst